Brainsway (BWAY) FCF Margin (2018 - 2026)
Brainsway (BWAY) posted quarterly FCF Margin of 12.49% for Q1 2026, down 3998.0% year-on-year from 0.32% in Q1 2025, and up 189.9% on a QoQ basis from 13.89% in Q4 2025.
Brainsway (BWAY) FCF Margin (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported FCF Margin for 9 consecutive years, with 12.49% the latest figure, recorded in Q1 2026.
- Quarterly FCF Margin fell 3998.0% year-over-year to 12.49% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 27.84% (down 953.0% YoY) and the FY2025 annual result came in at 36.83%, up 247.0% from the prior year.
- FCF Margin rose to 12.49% in Q1 2026 per BWAY's latest filing, from 13.89% in the prior quarter.
- Over the last five years, FCF Margin for BWAY reached as high as 107.26% in Q2 2025 and fell as low as 53.45% in Q1 2023.
- A 5-year average of 11.7% and a median of 21.94% in 2024 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2024 — FCF Margin surged 9635 bps — and 2025, when it slumped 5259 bps.
- Year by year, FCF Margin stood at 37.18% in 2022, then surged by 187 bps to 32.3% in 2023, then climbed by 20 bps to 38.7% in 2024, then tumbled by 136 bps to 13.89% in 2025, then soared by 190 bps to 12.49% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 12.49%, 13.89%, and 16.18% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | 12.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.49% |
| Dec 31, 2025 | -13.89% |
| Sep 30, 2025 | 16.18% |
| Jun 30, 2025 | 107.26% |
| Mar 31, 2025 | 52.47% |
| Dec 31, 2024 | 38.70% |
| Sep 30, 2024 | 34.07% |
| Jun 30, 2024 | 21.94% |
| Mar 31, 2024 | 42.90% |
| Dec 31, 2023 | 32.30% |
| Sep 30, 2023 | 22.52% |
| Jun 30, 2023 | 31.83% |
| Mar 31, 2023 | -53.45% |
| Dec 31, 2022 | -37.18% |
| Sep 30, 2022 | -43.01% |
| Jun 30, 2022 | -28.80% |
| Mar 31, 2022 | -37.48% |
| Dec 31, 2021 | 3.23% |
| Sep 30, 2021 | -5.09% |
| Jun 30, 2021 | -18.29% |